Tag: pharmaceuticals
-
Trials Adding Covid-19 Hospital, Out-Patient Therapies
National Institutes of Health is adding a new treatment to a clinical trial for Covid-19 patients hospitalized with severe respiratory failure.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.
-
Start-Up Designing Synthetic DNA for Gene Therapies
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses.
-
Challenge Trial Testing Covid-19 Reinfection
A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus.
-
Infographic – Israel Halts Covid-19 Spread with Vaccines
Israel is emerging as the world’s leader in vaccinating its population, and seeing results in declines of new Covid-19 cases.
-
Lilly Asks FDA to Revoke Covid-19 Therapy Clearance
Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-
Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-
Antibody Cocktail Prevents Covid-19 Disease Symptoms
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients.